The Company to host an earnings conference call via webcast on September 9, 2021, at the close of market VICTORIA, British Columbia — IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibody discovery and development, today announced that it will host a conference call to discuss […]
Read More